TELA Bio
TELA on Nasdaq. Market value $51m.
Should I look at this?
We have not checked this company yet
This is not advice.
Who owns it
None of the long-term investors we follow own it. 45 funds in all.
Largest holders overall
- Nantahala Capital Management$9mAdded
- Essex Woodlands Management$6m
- Stonepine Capital Management$2m
- Silverarc Capital Management$2mCut
- Vanguard Capital Management$1m
- DAFNA Capital Management$1m
- Perkins Capital Management$1mCut
- Sio Capital Management$477,225
- WealthTrust Axiom$343,300Added
- Geode Capital Management$291,952Cut
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
10 investors own more than 5%.
- EW Healthcare Partners Fund 2 GP, L.P.Passive investorat least 17.3%(filed with 2 related holders)Since 17 November 2025
- EW Healthcare Partners Fund 2-GP, L.P.at least 17.2%+10.4 pts(filed with 3 related holders)Since 9 June 2026
What they said
The disclosure set forth in Item 6 below is hereby incorporated by reference in this Item 4. This Schedule 13D reports that, on June 9, 2026, an operating partner affiliated with the Reporting Persons was appointed to the Board of Directors of the Issuer. Except as described…
Read the filing - Nantahala Capital Management, LLCPassive investorat least 12.9%+0.0 pts(filed with 2 related holders)Since 30 June 2026
- North Run Capital, LPPassive investorat least 9.3%+4.3 pts(filed with 6 related holders)Since 31 March 2025
- Devesh S. GandhiPassive investor7.8%Since 31 December 2024
- Stonepine Capital Management, LLCPassive investorat least 6.0%(filed with 3 related holders)Since 31 December 2024
- Lytton, Laurence W.Passive investor5.5%−1.7 ptsSince 31 March 2026
- SilverArc Capital Management, LLCPassive investorat least 4.8%0.0 pts(filed with 1 related holder)Since 30 June 2026
- Orin HirschmanPassive investorat least 3.6%−3.2 pts(filed with 1 related holder)Since 31 March 2025
- GROW FUNDS, LLC.Passive investorn/aSince 30 September 2025
| Holder | Stake | Since | |
|---|---|---|---|
EW Healthcare Partners Fund 2 GP, L.P. Passive investor | at least 17.3% (filed with 2 related holders) | 17 November 2025 | |
EW Healthcare Partners Fund 2-GP, L.P. | at least 17.2%+10.4 pts (filed with 3 related holders) | 9 June 2026 | What they saidThe disclosure set forth in Item 6 below is hereby incorporated by reference in this Item 4. This Schedule 13D reports that, on June 9, 2026, an operating partner affiliated with the Reporting Persons was appointed to the Board of Directors of the Issuer. Except as described… Read the filing |
Nantahala Capital Management, LLC Passive investor | at least 12.9%+0.0 pts (filed with 2 related holders) | 30 June 2026 | |
North Run Capital, LP Passive investor | at least 9.3%+4.3 pts (filed with 6 related holders) | 31 March 2025 | |
Devesh S. Gandhi Passive investor | 7.8% | 31 December 2024 | |
Stonepine Capital Management, LLC Passive investor | at least 6.0% (filed with 3 related holders) | 31 December 2024 | |
Lytton, Laurence W. Passive investor | 5.5%−1.7 pts | 31 March 2026 | |
SilverArc Capital Management, LLC Passive investor | at least 4.8%0.0 pts (filed with 1 related holder) | 30 June 2026 | |
Orin Hirschman Passive investor | at least 3.6%−3.2 pts (filed with 1 related holder) | 31 March 2025 | |
GROW FUNDS, LLC. Passive investor | n/a | 30 September 2025 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
In the last 12 months, 2 insiders bought $186,016 of shares on the open market.
- Capper Joseph HDirectorBought
- Date
- 17 September 2026
- Shares
- 25,000
- Price
- $1.22
- Value
- $30,530
- Capper Joseph HDirectorBought
- Date
- 16 September 2026
- Shares
- 50,000
- Price
- $1.17
- Value
- $58,265
- Capper Joseph HDirectorBought
- Date
- 15 September 2026
- Shares
- 50,000
- Price
- $1.06
- Value
- $52,940
- Capper Joseph HDirectorBought
- Date
- 14 September 2026
- Shares
- 25,000
- Price
- $1.02
- Value
- $25,503
- Getz Heather CChief Executive Officer, DirectorBought
- Date
- 17 August 2026
- Shares
- 12,500
- Price
- $0.66
- Value
- $8,311
- Getz Heather CChief Executive Officer, DirectorBought
- Date
- 14 August 2026
- Shares
- 15,000
- Price
- $0.70
- Value
- $10,467
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 17 September 2026 | Capper Joseph H Director | Bought | 25,000 | $1.22 | $30,530 |
| 16 September 2026 | Capper Joseph H Director | Bought | 50,000 | $1.17 | $58,265 |
| 15 September 2026 | Capper Joseph H Director | Bought | 50,000 | $1.06 | $52,940 |
| 14 September 2026 | Capper Joseph H Director | Bought | 25,000 | $1.02 | $25,503 |
| 17 August 2026 | Getz Heather C Chief Executive Officer, Director | Bought | 12,500 | $0.66 | $8,311 |
| 14 August 2026 | Getz Heather C Chief Executive Officer, Director | Bought | 15,000 | $0.70 | $10,467 |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
Not checked yet. We haven’t read TELA Bio’s annual report.
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.